FDA rejects Chiasma's drug to treat growth disorder

(Reuters) - The U.S. Food and Drug Administration on Friday rejected Chiasma Inc's drug to treat adults with a type of growth disorder.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro